Diagnosis and Treatment > Medication

You are looking at 1 - 1 of 1 items for :

  • Phytohaemagglutinin induced interferon gamma x
  • Triiodothyronine (T3) x
Clear All
K Majumdar University College London Hospitals NHS Foundation Trust, Diabetes and Endocrinology, 250 Euston Road, London NW1 2PG, UK

Search for other papers by K Majumdar in
Google Scholar
PubMed
Close
,
M Barnard Whittington Hospital, London, UK

Search for other papers by M Barnard in
Google Scholar
PubMed
Close
,
S Ramachandra Whittington Hospital, London, UK

Search for other papers by S Ramachandra in
Google Scholar
PubMed
Close
,
M Berovic Whittington Hospital, London, UK

Search for other papers by M Berovic in
Google Scholar
PubMed
Close
, and
M Powell National Hospital for Neurology and Neurosurgery, Neurosurgery, London, UK

Search for other papers by M Powell in
Google Scholar
PubMed
Close

Summary

Tuberculosis (TB) is an important cause of mortality and morbidity across the world. In 2–5% of all cases of systemic TB, the C is affected, with lesions reported in the meninges, cortex and ventricles. Intrasellar tuberculomas, however, are extremely rare. We report the interesting case of a young female patient who presented with secondary hypothyroidism and hyperprolactinaemia. She was treated successfully for pituitary TB. We also highlight and discuss some interesting (and hitherto unreported) endocrine issues. Radiological and histological features and treatment of pituitary TB are discussed using this case as an example.

Learning points

  • Intrasellar TB continues to be a rare presentation, but incidence and prevalence are expected to grow with increasing numbers of multidrug-resistant TB and shrinking geographical boundaries across the world.

  • Pituitary TB can present with features of a typical adenoma, but has certain radiological and histological features that help to differentiate from an adenoma.

  • Patients can present with a variety of endocrine abnormalities at different times.

  • The presence of an intrasellar mass in individuals at a high risk of developing TB, or with a previous history of systemic TB, should prompt the diagnosis of pituitary TB. In such individuals, it may be worth considering a trial of anti-tuberculous therapy, before considering surgery.

Open access